Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rak

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Allergy|October 3, 2002
Treatment of asthmatic patients with a cysteinyl leukotriene receptor-1 antagonist montelukast (Singulair), decreases the eosinophil survival-enhancing activity produced by peripheral blood mononuclear leukocytes in vitroK Becler, L Håkansson, S Rak
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 15, 1999
The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lungM Lampinen, S Rak, P Venge
International Archives of Allergy and Applied Immunology|January 1, 1987
Eosinophil chemotactic activity in allergic patients during the birch pollen season: the effect of immunotherapyS Rak, L Håkansson, P Venge
Allergy|April 9, 2005
Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapyS Rak, C Heinrich, A Scheynius
The Journal of Allergy and Clinical Immunology|March 17, 2000
Demonstration of mast cell chemotactic activity in bronchoalveolar lavage fluid collected from asthmatic patients before and during pollen seasonN Olsson, S Rak, G Nilsson
The Journal of Allergy and Clinical Immunology|November 1, 1990
Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen seasonS Rak, L Håkanson, P Venge
Allergy|May 23, 1998
Allergen-specific increase in interleukin (IL)-4 and IL-5 secretion from peripheral blood mononuclear cells during birch-pollen immunotherapyR Movérare, S Rak, L Elfman
Advances in Experimental Medicine and Biology|January 1, 1987
Effect of substance P on human lymphocyte proliferation in vitro: a comparison between normal and birch pollen allergic individualsG Nilsson, S Rak, S Ahlstedt
Allergy|October 1, 1987
The influence of substance P on the proliferation of peripheral blood lymphocytes from normal individuals and birch pollen-allergic patientsG Nilsson, S Rak, S Ahlstedt
Allergy|December 17, 2003
Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients: a double blind placebo-controlled studyM B Arvidsson, O Löwhagen, S Rak
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Allergy|October 3, 2002
Treatment of asthmatic patients with a cysteinyl leukotriene receptor-1 antagonist montelukast (Singulair), decreases the eosinophil survival-enhancing activity produced by peripheral blood mononuclear leukocytes in vitroK Becler, L Håkansson, S Rak
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 15, 1999
The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lungM Lampinen, S Rak, P Venge
International Archives of Allergy and Applied Immunology|January 1, 1987
Eosinophil chemotactic activity in allergic patients during the birch pollen season: the effect of immunotherapyS Rak, L Håkansson, P Venge
Allergy|April 9, 2005
Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapyS Rak, C Heinrich, A Scheynius
The Journal of Allergy and Clinical Immunology|March 17, 2000
Demonstration of mast cell chemotactic activity in bronchoalveolar lavage fluid collected from asthmatic patients before and during pollen seasonN Olsson, S Rak, G Nilsson
The Journal of Allergy and Clinical Immunology|November 1, 1990
Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen seasonS Rak, L Håkanson, P Venge
Allergy|May 23, 1998
Allergen-specific increase in interleukin (IL)-4 and IL-5 secretion from peripheral blood mononuclear cells during birch-pollen immunotherapyR Movérare, S Rak, L Elfman
Advances in Experimental Medicine and Biology|January 1, 1987
Effect of substance P on human lymphocyte proliferation in vitro: a comparison between normal and birch pollen allergic individualsG Nilsson, S Rak, S Ahlstedt
Allergy|October 1, 1987
The influence of substance P on the proliferation of peripheral blood lymphocytes from normal individuals and birch pollen-allergic patientsG Nilsson, S Rak, S Ahlstedt
Allergy|December 17, 2003
Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients: a double blind placebo-controlled studyM B Arvidsson, O Löwhagen, S Rak
Pageof 8